These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
156 related articles for article (PubMed ID: 32643837)
1. Predicting inadequate treatment response in children with chronic spontaneous urticaria. Park YM; Oh MS; Kwon JW Pediatr Allergy Immunol; 2020 Nov; 31(8):946-953. PubMed ID: 32643837 [TBL] [Abstract][Full Text] [Related]
2. Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE study. Bérard F; Ferrier Le Bouedec MC; Bouillet L; Reguiai Z; Barbaud A; Cambazard F; Milpied B; Pelvet B; Kasujee I; Gharbi H; Lacour JP Br J Dermatol; 2019 Jan; 180(1):56-66. PubMed ID: 29927483 [TBL] [Abstract][Full Text] [Related]
3. Correlation of urticaria activity score in chronic spontaneous urticaria with serum C-reactive protein level and neutrophil/lymphocyte ratio. Akca HM; Tuncer Kara K Dermatol Ther; 2020 Nov; 33(6):e14532. PubMed ID: 33176046 [TBL] [Abstract][Full Text] [Related]
4. Consecutive injections of low-dose interleukin-2 improve symptoms and disease control in patients with chronic spontaneous urticaria. Wang J; He L; Yi W; Liang Q; Jiang L; Tan Y; Zhang G; Su Y; Xiao R; Lu Q; Long H Clin Immunol; 2023 Feb; 247():109247. PubMed ID: 36724835 [TBL] [Abstract][Full Text] [Related]
5. The persistence of chronic spontaneous urticaria in childhood is associated with the urticaria activity score. Arik Yilmaz E; Karaatmaca B; Cetinkaya PG; Soyer O; Sekerel BE; Sahiner UM Allergy Asthma Proc; 2017 Mar; 38(2):136-142. PubMed ID: 28234051 [TBL] [Abstract][Full Text] [Related]
6. The clinical and laboratory characteristics of acute spontaneous urticaria and its progression to chronic spontaneous urticaria. Magen E; Zueva E; Mishal J; Schlesinger M Allergy Asthma Proc; 2016 Sep; 37(5):394-9. PubMed ID: 27657523 [TBL] [Abstract][Full Text] [Related]
7. Serum Amyloid A as a Potential Biomarker for Disease Activity in Chronic Spontaneous Urticaria. Carvallo A; Veleiro B; Sabaté-Brescó M; Baeza ML; Guilarte M; Herrera-Lasso V; Rodríguez-Garijo N; Diaz Donado C; Labrador-Horrillo M; Ferrer M J Allergy Clin Immunol Pract; 2024 Jan; 12(1):195-200. PubMed ID: 37716523 [TBL] [Abstract][Full Text] [Related]
8. Validation of the Turkish version of the Urticaria Control Test: Correlation with other tools and comparison between spontaneous and inducible chronic urticaria. Kocatürk E; Kızıltaç U; Can P; Öztaş Kara R; Erdem T; Kızıltaç K; Sahillioğlu N; Gelincik A; Maurer M; Weller K World Allergy Organ J; 2019; 12(1):100009. PubMed ID: 30937134 [TBL] [Abstract][Full Text] [Related]
9. An observational study on the efficacy of single injection of omalizumab in the treatment of chronic spontaneous urticaria. Lal Vijayalal S; Arora S; Dabas R; Janney MS; Jankal Basavarajappa S; Das NM Dermatol Ther; 2020 Nov; 33(6):e14397. PubMed ID: 33040395 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness of omalizumab in chronic spontaneous urticaria assessed with patient-reported outcomes: a prospective study. Ghazanfar MN; Holm JG; Thomsen SF J Eur Acad Dermatol Venereol; 2018 Oct; 32(10):1761-1767. PubMed ID: 29729103 [TBL] [Abstract][Full Text] [Related]
11. An Open-Label, Investigator-Initiated, Single-Centre Pilot Study to Determine the Safety and Efficacy of Tofacitinib in Resistant Chronic Spontaneous Urticaria. De A; Pal S; Singh S; Chakroborty D; Godse K Indian J Dermatol; 2024; 69(4):312-316. PubMed ID: 39296701 [TBL] [Abstract][Full Text] [Related]
12. The Urticaria Activity Score-Validity, Reliability, and Responsiveness. Hawro T; Ohanyan T; Schoepke N; Metz M; Peveling-Oberhag A; Staubach P; Maurer M; Weller K J Allergy Clin Immunol Pract; 2018; 6(4):1185-1190.e1. PubMed ID: 29128337 [TBL] [Abstract][Full Text] [Related]
13. Headache deteriorates the quality of life in children with chronic spontaneous urticaria. Filiz S; Kutluk MG; Uygun DFK Allergol Immunopathol (Madr); 2019; 47(3):254-259. PubMed ID: 30686612 [TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up effect of omalizumab in chronic spontaneous urticaria and its association with serum C-reactive protein levels. Baysak S; Sevim Kecici A; Dogan B Dermatol Ther; 2020 Jul; 33(4):e13663. PubMed ID: 32447802 [TBL] [Abstract][Full Text] [Related]
15. Validation of the Urticaria Control Test (UCT) in Children With Chronic Urticaria. Prosty C; Gabrielli S; Mule P; Noorah N; Baum S; Greenberger S; Ensina LF; Zhang X; Netchiporouk E; Ben-Shoshan M J Allergy Clin Immunol Pract; 2022 Dec; 10(12):3293-3298.e2. PubMed ID: 35973527 [TBL] [Abstract][Full Text] [Related]
16. Prognostic Factors for Chronic Spontaneous Urticaria: A 6-Month Prospective Observational Study. Ye YM; Park JW; Kim SH; Ban GY; Kim JH; Shin YS; Lee HY; Park HS; Allergy Asthma Immunol Res; 2016 Mar; 8(2):115-23. PubMed ID: 26739404 [TBL] [Abstract][Full Text] [Related]
17. Clinical and laboratory assessment for the inflammation role in chronic spontaneous urticaria: A clinical study. Ataseven A; Durmaz K; Temiz SA; Dursun R Dermatol Ther; 2020 Nov; 33(6):e14125. PubMed ID: 32761761 [TBL] [Abstract][Full Text] [Related]
18. Relationship between Blastocystis spp. with Accompanying Food Hypersensitivity and Chronic Spontaneous Urticaria. Tuzer C; Yegit O; Ozturk NS; Demir S; Demirpek U; Boral OB; Buyukozturk S; Gelincik A; Colakoglu B Int Arch Allergy Immunol; 2022; 183(12):1259-1269. PubMed ID: 36108617 [TBL] [Abstract][Full Text] [Related]
19. Basophil CD63 expression in chronic spontaneous urticaria: correlation with allergic sensitization, serum autoreactivity and basophil reactivity. Chen Q; Zhai Z; Xu J; Chen W; Chen S; Zhong H; Huang X; Hao F; Song Z J Eur Acad Dermatol Venereol; 2017 Mar; 31(3):463-468. PubMed ID: 27518369 [TBL] [Abstract][Full Text] [Related]
20. Omalizumab in chronic spontaneous urticaria: Efficacy, safety, predictors of treatment outcome, and time to response. Nettis E; Cegolon L; Di Leo E; Lodi Rizzini F; Detoraki A; Canonica GW; Ann Allergy Asthma Immunol; 2018 Oct; 121(4):474-478. PubMed ID: 29949781 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]